Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Daclizumab may have applications in uveitis therapy

June 25, 1999

Bausch & Lomb to collaborate on ophthalmic drug delivery technology

June 23, 1999

InSite Vision's ISV-205 achieves positive results in phase II study

June 23, 1999

Another European market introduction announced for emedastine

June 4, 1999

SKK-60060: new selectin inhibitor effective in animal model of retinal ischemia-reperfusion injury

June 4, 1999

Health Canada approves Cosopt glaucoma treatment

June 4, 1999

Potential new use for diphenhydramine in uveitis

June 4, 1999

VEGF TK inhibitors described by Merck for angiogenic ocular disorders

May 20, 1999

Alcon launches emedastine in U.K. for treatment of seasonal allergic conjunctivitis

May 17, 1999

Postmarketing studies of latanoprost support efficacy, safety of antiglaucoma agent

May 14, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...